63 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
23 Jul 21
Other Events
5:20pm
effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees
8-K
EX-99.1
TPST
Tempest Therapeutics Inc
16 Jul 21
Other Events
4:31pm
necessary, the lead plaintiff publicly filed its second amended complaint; and defendants filed their answers and affirmative defenses to the second
424B3
TPST
Tempest Therapeutics Inc
11 May 21
Prospectus supplement
5:19pm
incomplete and misleading registration statement with the SEC in connection with the proposed merger. The plaintiff seeks to enjoin the defendants from … proceeding with a shareholder vote on the proposed merger until the Company discloses the material. The plaintiff also seeks damages and an award